Major vendors picked up where they left off last year in the development of hybrid PET/CT systems, extending technology to its furthest capabilities or tweaking existing products for specialty applications. Premium performance 16-slice CT scanners were
Major vendors picked up where they left off last year in the development of hybrid PET/CT systems, extending technology to its furthest capabilities or tweaking existing products for specialty applications. Premium performance 16-slice CT scanners were added to PET scanners, either as commercial products or on the drawing board, and a compact PET/CT optimized for oncology was displayed. The goal behind each was simple: to improve efficiency either by reducing scan time or conserving space and lowering cost to the customer.
CTI
The company, a longtime leader in PET development, albeit behind the scenes as a supplier to Siemens, is determined to step from behind the curtains with its own products while maintaining its fruitful relationship with the German vendor. CTI also designs and manufacturers cyclotrons and PET chemistry systems.
Gamma Medica Instruments
The company targets niche markets with its line of LumaGem scintillation cameras. A primary focus is women's healthcare.
GE Medical Systems
Only a few years ago, GE was struggling to be taken seriously as a major vendor of nuclear medicine equipment. Corporate acquisitions of SMV and the nuc med assets of Elscint, along with a renewed focus on PET, have helped make the company one of the premier players in the segment.
Hitachi Medical Systems America
Hitachi entered the PET marketplace in 2002 with the Sceptre PET system, a value-priced PET scanner sourced from CTI PET Systems. The product, introduced at the June meeting of the Society of Nuclear Medicine, comes with the Avia fusion workstation.
Philips Medical Systems
Building on successes engineered by ADAC Laboratories, which it acquired in 2000, Philips continues to provide one of the most extensive lines of gamma cameras and PET scanners in the industry.
Positron
One of the first companies to develop commercial PET systems, Positron continues as a single-modality vendor of positron technology. The company showcased its air-cooled mPower whole-body scanner, which supports neurology, cardiology, and oncology exams. The scanner was introduced at the 2001 RSNA meeting.
Siemens Medical Systems
Once the undisputed leader in nuclear medicine, Siemens fell behind upstart ADAC in the mid-1990s, only to become a market leader again at the turn of the century with the success of its e.cam gamma camera and PET/CT biograph. Siemens supplies its core technology gamma cameras and workstations to Toshiba for private labeling.
Syncor
Long a leader in PET pharmaceutical distribution, Syncor also provides ancillary technology useful in the practice of nuclear medicine.
Toshiba America Medical Systems
Through its strategic alliance with Siemens, Toshiba America provides its own version of the e.cam gamma camera, dubbed T.Cam. Toshiba mirrored developments by Siemens, displaying its e.soft Signature Series workstation for the T.Cam variable-angle, dual-detector gamma camera, which is designed to deliver high performance and efficiency.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.